ResearcherNational Cancer Center HospitalActive in the last 2 years
Go Ikeda
Matched on ORCID iD 0009-0006-7333-7095; OpenAlex author ID A5077212591, A5121112149. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2022: 1 paper · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Tumor Cell Count and Total Cell Count as Surrogate Indicators of Comprehensive Genomic Profiling Success in Pancreatic Cancer Specimens Collected by Endoscopic… Co-author DOI 10.1002/jhbp.70106↗
- Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. Co-author DOI 10.1016/j.pan.2023.10.017↗
- Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for genomic profiling of unresectable pancr… Co-author DOI 10.1111/den.14423↗
- Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System … Co-author DOI 10.1007/s00535-022-01926-z↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Susumu Hijioka · 4 shared papers, 2022–2026 · strength 0.70
- Paper Tumor Cell Count and Total Cell Count as Surrogate Indicators of Comprehensive Genomic Profiling Success in Pancreatic … DOI 10.1002/jhbp.70106↗
- Paper Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. DOI 10.1016/j.pan.2023.10.017↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Takuji Okusaka · 4 shared papers, 2022–2026 · strength 0.70
- Paper Tumor Cell Count and Total Cell Count as Surrogate Indicators of Comprehensive Genomic Profiling Success in Pancreatic … DOI 10.1002/jhbp.70106↗
- Paper Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. DOI 10.1016/j.pan.2023.10.017↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Shota Harai · 3 shared papers, 2022–2026 · strength 0.53
- Paper Tumor Cell Count and Total Cell Count as Surrogate Indicators of Comprehensive Genomic Profiling Success in Pancreatic … DOI 10.1002/jhbp.70106↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Daiki Yamashige · 2 shared papers, 2023–2026 · strength 0.41
- Paper Tumor Cell Count and Total Cell Count as Surrogate Indicators of Comprehensive Genomic Profiling Success in Pancreatic … DOI 10.1002/jhbp.70106↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Nobuyoshi Hiraoka · 2 shared papers, 2023–2026 · strength 0.41
- Paper Tumor Cell Count and Total Cell Count as Surrogate Indicators of Comprehensive Genomic Profiling Success in Pancreatic … DOI 10.1002/jhbp.70106↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Hidetoshi Kitamura · 3 shared papers, 2022–2023 · strength 0.41
- Paper Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. DOI 10.1016/j.pan.2023.10.017↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Akihiro Ohba · 3 shared papers, 2022–2023 · strength 0.41
- Paper Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. DOI 10.1016/j.pan.2023.10.017↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Hideki Ueno · 3 shared papers, 2022–2023 · strength 0.41
- Paper Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. DOI 10.1016/j.pan.2023.10.017↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Chigusa Morizane · 3 shared papers, 2022–2023 · strength 0.41
- Paper Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. DOI 10.1016/j.pan.2023.10.017↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Yuya Hisada · 2 shared papers, 2022–2023 · strength 0.24
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Kotaro Takeshita · 2 shared papers, 2022–2023 · strength 0.24
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Yasushi Yatabe · 2 shared papers, 2022–2023 · strength 0.24
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Katsuhiko Iwakiri · 1 shared paper, 2023 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.